Long Ideas - The FDA posted notes Friday for its upcoming Advisory Committee meeting, stating that the governing body is in agreement with NPS Pharmaceuticals (NASDAQ:NPSP) on the … Continue Reading
Read NowLong Ideas - Two pertinent announcements from Lexicon Pharmaceuticals (NASDAQ:LXRX) are giving shares a 7% lift on Friday morning. The company reported top-line data from the latest Phase … Continue Reading
Read NowQuick Picks - This week, the FDA posted a warning letter to Akorn, Inc (NASDAQ:AKRX) dated October 2, warning the company that it is manufacturing an unapproved drug, … Continue Reading
Read NowQuick Picks - Shares of ArQule (NASDAQ:ARQL) are being crushed in early trading on Tuesday following an announcement that the company and partner Daiichi Sankyo (OTC:DSNKY) will be … Continue Reading
Read NowMost Popular - The FDA has scheduled an advisory committee meeting for Ampligen, a product developed by Hemispherx Biopharma (AMEX:HEB) for the treatment of Chronic Fatigue Syndrome (CFS), … Continue Reading
Read NowQuick Picks - Early Monday, Cell Therapeutics (NASDAQ:CTIC) announced that its JAK2 inhibitor pacritinib demonstrated good tolerability and evidence of cancer-fighting behavior in a 34 patient Phase I … Continue Reading
Read NowQuick Picks - By Jake King Vivus Inc. (NASDAQ:VVUS) announced Friday morning that, based on preliminary communication with European regulators, the company doubts it will receive approval of … Continue Reading
Read Now